Menichella Daniel L 4
4 · Kaleido Biosciences, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Menichella Daniel L
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+90,000→ 90,000 totalExercise: $9.81Exp: 2031-02-28→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on March 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.